A Prospective Study To Define The Role Of Various Factors In Development And Progression Of Gastroesophageal Reflux Disease (GERD) And Barrett's Esophagus And The Creation Of A Registry.

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The purpose of this study is to determine or evaluate the risk factors such as smoking, family history etc. that cause esophageal cancer and to determine the genetic changes that lead to esophageal cancer. The investigators hypothesis is that systematic collection of data on the natural history of GERD and BE patients and risk factors for development of BE in patients with chronic GERD and progression of BE to dysplasia and adenocarcinoma will provide useful information to develop a decision model for risk stratification and risk reduction strategies in these patients. As of March 17, 2011, 585 patients have consented at the Kansas City VA Medical Center.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Kansas City VA Patients with confirmed BE with and without dysplasia and patients with reflux disease (patients/cases); patients with other indicators for endoscopy such as anemia, weight loss, diarrhea, but without GERD and PE (controls).

Locations
United States
Missouri
Department of Veterans Affairs Medical Center
RECRUITING
Kansas City
Contact Information
Primary
April D Higbee, RN, BSN
april.higbee@va.gov
816-861-4700
Backup
Carly Campbell, MS
Carlissa.Campbell@va.gov
816-861-4700
Time Frame
Start Date: 2006-01
Estimated Completion Date: 2029-01
Participants
Target number of participants: 3000
Treatments
A- Barrett's Esophagus subjects
Patients with documented Barrett's Esophagus with or without dysplasia (LGD or HGD) that will undergo surveillance endoscopies dictated by the grade of dysplasia.
B- gastroesophageal reflux subjects
Patients undergoing endoscopy for evaluation of GERD symptoms.
C-subjects without BE or GERD
The control group would include patients undergoing upper endoscopy for reasons other than stated above, such as evaluation of iron deficiency anemia, weight loss, positive fecal occult blood, etc.
Sponsors
Collaborators: Kansas City Veteran Affairs Medical Center
Leads: Midwest Biomedical Research Foundation

This content was sourced from clinicaltrials.gov